PHYSICIANS

Expertise in Neurophysiology, Multiple Sclerosis, Botulinum Toxin, Headache

Prof. Salam Koussa is an attending neurologist at the Clemenceau Medical Center, Beirut. He is also director of the Multiple Sclerosis Center at the Geitaoui Lebanese University Hospital, Beirut.
He trained at different prestigious French institutions like Pitié Salpêtrière University Hospital in Paris, France. He is French board certified in neurology. He is Professor of Neurology at the Lebanese University, Beirut. He was Professor of Neurology and Head of the Department of Neurology at the St-Joseph University-Faculty of Medicine, Beirut. He was chief of the Department of Neurology at Hôtel-Dieu de France, Beirut.

Prof. Koussa is currently working on many research projects in multiple sclerosis, botulinum toxin in spasticity and dystonia, and headache. He has many publications in different medical journals.  He is a member of many medical societies.  Prof. Koussa gave many medical conferences at different institutions, hospitals and medical meetings.

 

Professor of Neurology at the Lebanese University, Beirut.

Degrees

1981: Diploma of Doctor in Medicine, St-Joseph University, Beirut
1981: Doctor in Medicine, French Diploma (awarded by the State of France)
1981: ECFMG (Score : 81)
1985: French Board of Neurology (CES de Neurologie, Diplôme d’État Français)
1988: Diploma of Medical and Surgical Anatomy (Option: Neuroanatomy), Paris VI University
1989: Diploma of Clinical Neurophysiology, Paris VI University
1990: Diploma of Neuro-Muscular Functional Explorations, Paris VI University
2010: Diploma of Specialized Education in Medical Sciences, St-Joseph University, Beirut

 

-JC Gautier, JB Juillard, S Koussa, P Loron, A Majdalani, S Timsit. Accidents ischémiques transitoires : épidémiologie, étiologie, physiopathologie, diagnostic, évolution, pronostic, traitement. Rev Prat (Paris), 1988, 38, 23 : 1669-1673
-JC Gautier, A Dürr, S Koussa, G Lascault, Y Grosgogeat. Embolies cérébrales paradoxales : rôle du foramen ovale perméable. Bull Acad Nale Med (Paris), 1990, 174, 7: 1031-1040
-JC Gautier, A Dürr, S Koussa, G Lascault, Y Grosgogeat. Paradoxical embolism with a patent foramen ovale. Cerebrovasc Dis, 1991, 1 : 193-202
-K Khouri, S Koussa, C Yaghi. Un cas de trichinose révélée par une diarrhée prolongée et des signes neurologiques. Journal Médical Libanais, 1993, 41, 3 : 163-167
-A Tohmé, L Mattar, A Zébouni, S Koussa. Pemphigoïde bulleuse et sclérose en plaques. Ann Dermatol Vénéréol (Paris), 1994, 121, 139-142
-S Koussa, R Chémaly, V Fabre-Bou Abboud, J Tamraz, N Haddad. Trichinose et occlusions sino-veineuses cérébrales. Rev Neurol (Paris), 1995, 150, 6-7: 464-466
-R Chémaly, G Halaby, G Mohasseb, R Medlej, J Tamraz, S Koussa. Myélinolyse extrapontine : traitement par TRH. Rev Neurol (Paris), 1998, 153, 2 : 163-165 
-S Koussa, R Slim, T Rizk, J Tamraz, R Chémaly. Adrénoleucodystrophie à forme frontale pseudo-tumorale. Rev Neurol (Paris), 2000, 156, 11: 1017-1019
-T Rizk, R Nabbout, S Koussa, C Akatcherian. Congenital brain tumor, in a neonate conceived by in vitro fertilization. Child’s Nerv Syst, 2000, 16: 501-502
-V Delague, C Bareil, S Tuffery, P Bouvagnet, E Chouery, S Koussa, T Maisonobe, J Loiselet, A Mégarbané, M Claustres. Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q 13.1-13.3 in a large consanguineous Lebanese family: exclusion of MAG as a candidate gene. Am J Hum Genet, 2000, 67: 1015-1022
-S Koussa, J Tamraz, R Nasnas. Leucoencephalopathy after heroin inhalation: a case with partial regression of MRI lesions. J Neuroradiol, 2001, 28: 268-271
-J Pascal, G Bussone, JF Hernandez and the Rizatriptan-Sumatriptan Preference Study Group. Comparaison of preference for Rizatriptan 10-mg Wafer versus Sumatriptan 50-mg Tablet in Migraine. Eur Neurol, 2001, 45: 275-283
-T Rizk, G Abi Lahoud, J Maarrawi, R Hourani, P Jabbour, S Koussa, N Okais. Acute paraplegia revealing an intraspinal neurenteric cyst in a child: case report. Child’s Nerv Syst, 2001, 17, 12: 754-757
-S Koussa, R Zabad, T Rizk, J Tamraz, R Nasnas, R Chémaly. La leucoencéphalopathie vacuolaire induite par l’héroïne : 4 cas (mémoire). Rev Neurol (Paris), 2002, 158, 2: 177-182 
-S Koussa, R Nasnas. Catatonia and parkinsonism due to extrapontine myelinolysis following rapid correction of hyponatremia. J of Neurol, 2003, 250, 1: 103-105 
-P Jabbour, E Samaha, G Abi Lahoud, S Koussa, G Abadjian, G Nohra, T Rizk, R Moussa, N Okais. Hemicerebellitis mimicking a tumour on MRI. Child’s Nerv Syst, 2003, 19, 2: 122-125
-A Chehal, E. Aoun, S Koussa, H Skoury, S Koussa, A Taher. Hypertransfusion: a successful modality of treatment in thalassemic patients with spinal cord compression secondary to extramedullary hematopoiesis. Spine, 2003, 328, 13: 245-249
-S Koussa, R Chémaly. Neurobrucellosis presenting as diffuse cerebral white matter lesions. Eur  Neurol, 2003, 50 : 121-123
-S Koussa, T Rizk, A Tohmé. Crises d’épilepsie induites par le tramadol. Rev Neurol (Paris) 2003,159 : 1053-1054
-S Koussa, R Sayegh, A Taher. Tremblement postural et cinétique associé à un déficit en vitamine B12. Rev Neurol (Paris), 2003, 159: 12, 1173-174
-S Koussa, A Tohmé, E Ghayad, R Nasnas, K Kallab, R Chémaly. La neurobrucellose : étude de 15 patients (mémoire). Rev Neurol (Paris), 2003, 159 : 12, 1148-1155
-A Tohmé, E Zein, B el Rassi, S Koussa, R Nasnas. Brucellose humaine au Liban : étude clinique et thérapeutique de 88 patients. J Médical Libanais,  2004, 52 : 3, 149-155
-A Checrallah, S Geha, T Rizk, S Koussa. Forme rare d’une sclérose en plaque révélée par une pseudotumeur cérébrale. J Médical Libanais,  2005, 53 : 1, 45-49
-S Koussa, H Roukoz, T Rizk, A Mégarbané. Leucoencéphalopathie mégalencéphalique avec kystes sous-corticaux : étude d’une famille libanaise et revue de la littérature (mémoire). Rev Neurol  (Paris), 2005, 161: 2, 183-191
-S Koussa, J Tamraz, E Samaha. Hémichorée-hémiballisme récidivant, révélateur d’une hyperglycémie non-acidocétosique. J Neuroradiol (Paris), 2005, 32: 281-282
-C Yaghi, P Baz, S Koussa, F Daniel, F Haddad, R Sayegh. Neuropathie optique ischémique antérieure compliquant un traitement par interféron alpha-2a et ribavirin pour une hépatite C aigue. Gastroenterol Clin Biol, 2005, 29: 616-617 
-S Koussa, S Hage Chahine, E Samaha, M Riachi. Generalized status epilepticus possibly induced by gatifloxacin. Eur J Neurol,  2006, 13: 671-672 
-S Koussa, S Hage Chahine, A Tohmé, M Riachi. Crise d’épilepsie et vardenafil. Rev Neurol (Paris), 2006, 162: 651-652
-S Koussa, S Hage Chahine, A Zoghbi, P Yazbeck. Etat de mal épileptique et gatifloxacine. Rev Neurol (Paris), 2007, 163 : 99-101
-M Aldosari, S Bohlega, M Al-Jadid, M El-Tamawy, M Ramadan, Y Mousali, A Yaghmour, A Kurdi, S Koussa, S Khamis, V Zeljic, H Chacfe, F Molteni. Pan-Arab consensus statement on the use of botulinum toxin type A in spasticity management.  Neurosciences, 2007, 12: 279-281
-C Karam, S Koussa. Syndrome d’Eagle: apport du scanner avec reconstructions 3D. J Neuroradiol (Paris),  2007, 34 : 344-348
-E Choeiry, V Delague, A Bergougnoux, S Koussa, J-L Serre, A Mégarbané. Mutations in TREM2 lead to pure early-onset dementia without bone cysts. Human Mutation, 2008, 29: 194-2004
-M Riachy, F Sfeir, G Sleilaty, S Hage Chahine, G Dabar, T Bazerbachi, Z Aoun-Bacha, G Khayat, S Koussa. Prediction of the survival and functional ability of severe stroke patients admitted into an intensive care unit.  BMC Neurol, 2008, Jun 26; 8: 24
-C Karam, S Koussa. Cerebral dural sinus thrombosis following cisplatin chemotherapy. J Clin Neurosci, 2008, 15: 1274-1275
-A Tohmé, S Koussa, S Haddad-Zébouni, B El-Rassi, E Ghayad. Neurological manifestations of Behcet's disease: 22 cases among 170 patients. Presse Med, 2009, 38, 701-709

-R Rahmé, S Koussa, E Samaha . C1 arch regeneration, tight cisterna magna, and cervical syringomyelia following foramen magnum surgery.  Surg Neurol, 2009, 72: 83-85
-R Slim, S Koussa, H Awada, C Yaghi, K Honein, R Sayegh. Migration in two directions. Lebanese Medical J, 2009, 57: 271-273
-Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N Engl J Med, 2010, 362:416-26
-S, Rustom M. Association between myasthenia gravis and extrathymic non-Hodgkin's lymphoma. Rev Neurol (Paris), 2010 Aug-Sep, 8-9:752-753
-Haddad F, Anouti S, Maalouly G, Koussa S. Narcolepsy associated with systemic lupus erythematosus. Rev Med Int (Paris), 2010, 09.005. Epub 2010 Dec 8
-Haddad F,  Jammal M, Chehwane D, Abi Saleh R, Koussa S. Trouble de la marche révélant un SIADH associé à la prégabaline. Rev Med Int (Paris), 2012 Nov; 33(11):e49-51
-Shatila AR, Koussa S, Jabbour R, Mourad A, Aouad A, Sabbagh G, Kallab K, Hilal R, Khalifeh R, Gebeily S, Tourbah A. LSN MS guidelines for the management of multiple sclerosis. Rev Neurol (Paris), 2013 Feb S0035-3787(13)00028-3. [Epub ahead of print]
-Alroughani RA, Aref HM, Bohlega SA, Dahdaleh MP, Feki I, Al Jumah MA, Al-Kawi MZ, Koussa SF, Sahraian MA, Alsharoqi IA, Yamout BI. Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring. BMC Neurol, 2014 Feb 12;-14-27. Review

-Yamout B, Alroughani R, Al-Jumah M, Goueider R, Dahdaleh M, Inshasi J, Hashem S, Alsharoqi I, Sahraian M, Khoury S, Alkawi Z, Koussa S, Zakaria M, Al Khaburi J, Alsaadi T, Bohlega S. Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS). Curr Med Res Opin, 2015 Jul; 31(7):1349-61

-Bou Khalil R, Khoury E, Koussa S. Linking multiple pathogenic pathways to Alzheimer’s disease. Review. World J Psychiatry, 2016, Jun 22
-Amarenco P and TIA registry org investigators. One-Year Risk Stroke after Transient Ischemic Attack or Minor Stroke. N Engl J Med, 2016, Apr 21   
-Macaron G, El Rassy E, Koussa S. Morvan Syndrome Secondary to Thymic Carcinoma in a Patient with Systemic Lupus Erythematosus. Case Reports in Neurological Medicine, 2016, Article ID 9142486, 3 pages http://dx.doi.org/10.1155/2016/9142486
-Misra VP and INTEREST in CD2 study group. A global patient-centered study of long-term cervical dystonia treatment with botulinum toxin. J Neurol, 21 Dec 2017 (Epub)
-El-Bazzal L, Rihan K, Bernard-Marissal N, Castro C, Chouery-Khoury E, Desvignes JP, Atkinson A, Bertaux K, Koussa S, Levy N, Bartoli M, Megarbane A, Jabbour R, Delague V. Loss of Cajal bodies in motor neurons from patients with novel mutations in VRK1. Hum Mol Genet, 15 Jul 2019
-El-Hayeck R, Baddoura R, Wehbe A, Bassil N, Koussa S, Abou Khaled K, Richa S, Khoury R, Alameddine A, Sellal F. An Arabic Version of the Mini-Mental State Examination for the Lebanese Population: Reliability, Validity, and Normative Data. J Alzheimer Dis, 2019, Aug 12
-Colosimo C et al. How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment?  Results from a prospective, long term observational study. J Neurol, Sep 2019
-Yamout B, Sahraian M, Bohlega S, Al-Jumah M, Goueider R, Dahdaleh M, Inshasi J, Hashem S, Alsharoqi I, Khoury S, Alkhawajah M, Koussa S, Al Khaburi J, Almahdawi A, Alsaadi T, Slassi E, Daodi S, Zakaria M, Alroughani R. Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines. Mult Scler Relat Disord, 2020, Jan; 37:101459. doi: 10.1016/j.msard.2019.101459. Epub 2019 Oct 18.PMID: 31670208
-AlSharoqi IA, Aljumah M, Bohlega S, Boz C, Daif A, El-Koussa S, Inshasi J, Kurtuncu M, Müller T, Retief C, Sahraian MA, Shaygannejad V, Slassi I, Taha K, Zakaria M, Sørensen PS. Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing-Remitting Multiple Sclerosis Patients? A Narrative Review. Neurol Ther, 2020, Jun; 9(1):55-66. doi: 10.1007/s40120-020-00187-3. Epub 2020 Apr 15.PMID: 32297127
-Makhoul J, Ghaoui N, Sleilaty G, Koussa S, Abbas S, Azar C, El Helou J. Restless legs syndrome among multiple sclerosis patients in Lebanon. Mult Scler Relat Disord, 2020, Jun; 41: 101997. doi: 10.1016/j.msard.2020.101997. Epub 2020 Feb 11.PMID: 32113183
-Takao Hoshino and TIA registry.org Investigators. Five-Year Prognosis After TIA or Minor Ischemic Stroke in Asian and Non-Asian Populations. Observational Study. Neurology, 2021, Jan 5; 96(1):e54-e66 doi: 10.1212/WNL.0000000000010995. Epub 2020 Oct 12
An Arabic version of the Test of Nine Images for the illetrate Lebanese population: validation and normative data. R El-Hayeck, R Baddoura, A Wehbe, N Bassil, S Koussa, K Abou Khaled, S Richa, R Khoury, A Alameddine, F Sellal. (Submitted for review)

Abstracts accepted by a board of scientific reviewers:
-R Chémaly, A Tohmé, S Koussa, K Kallab, E Ghayad, R Nasnas. La neurobrucellose. Rev Neurol (Paris), 2000, 156, 3 : 307
-R Zabad, S Koussa, W Coplin. Chasing the Dragon: The Lebanese Experience. Neurology, 2001, 56, suppl 3: P06.056
-S  Koussa. Place de l’électrodiagnostic dans les radiculopathies cervicales. Rev Neurol (Paris), 2003, suppl. au n. 3 : 229
-S Koussa, H Roukoz, A Mégarbané. Leucoencephalopathie mégalencéphalique vacuolisante avec kystes sous-corticaux. Rev Neurol (Paris), 2004, suppl. au n. 4 : 159
-A Tohmé, B el Rassi, S Koussa, R Nasnas. Human brucellosis: clinical features and therapeutical responses in 92 patients. International J of Antimicrobial Agents, 2004, 24S, S77-S123
-S Koussa, S Hage Chahine, E Samaha, A Tohmé, M Riachi. Generalized status epilepticus possibly induced by gatifloxacin. Eur J Neurol, 2005, 12, suppl. 2, 122-123
-S Koussa, A Tohmé, F Haddad, E Ghayad. Manifestations neurologiques de la maladie de Behçet: étude de 16 observations. Rev Neurol (Paris), 2005, 161, 12: 1242-1243
-A Tohmé, S Koussa, S. Haddad-Zébouni, E Ghayad. Manifestations neurologiques de la maladie de Behçet. Etude de 22 observations. Rev Med Int (Paris), 2006, S303
-S Koussa, S Hage Chahine, A Zoghbi, P Yazbeck. Etat de mal épileptique et gatifloxacine. Rev Neurol (Paris), 2007, 163: 484-485
-K Abou Khaled, S Koussa, R Chemaly. Isolated vertigo as a manifestation of stroke. Rev Neurol (Paris), 2007, 163: 491
-S Koussa, R Mehanna, F El Hajj, S Mallat. Cerebral dural sinus thrombosis possibly induced by cisplatin-containing chemotherapy. Eur J Neurol, 2007, 14, suppl. 1, 132
-F Haddad, G Maalouly, M Jammal, G Asmar, W Kamouh, E Zein, S Koussa. Atteinte du douzième nerf crânien au cours de la fièvre méditerranéenne familiale. Rev Med Int (Paris), 2008, CA 195, 295 : S174-S175
-S Koussa. Heroin-induced spongiform leucoencephalopathy. Rev Neurol (Paris), 2008, 164: 873
-F Haddad, M Jammal, G Maalouly, R Abi Saleh, D Chehwane, S Koussa.  “B12” normal associée a des troubles cognitifs: mythe ou réalité? Rev Med Int (Paris), 2011, 32, S93

-Haddad F, Jammal M, Chehwane D, Abi Saleh R, Koussa S. Gait instability revealing a syndrome of inappropriate antidiuretic hormone secretion associated to pregabalin]. Rev Med Inter (Paris). 2012 Nov; 33(11) :e49-51 Epub 2012 Sep 23. French

-Shatila AR, Koussa S, Jabbour R, Mourad A, Aouad A, Sabbagh G, Kallab K, Hilal R, Khalifeh R, Gebeily S, Tourbah A. LSN MS guidelines for the management of multiple sclerosis. Rev Neurol (Paris), 2013 Feb 19. S0035-3787(13)00028-3. [Epub ahead of print]
-Alroughani RA, Aref HM, Bohlega SA, Dahdaleh MP, Feki I, Al Jumah MA, Al-Kawi MZ, Koussa SF, Sahraian MA, Alsharoqi IA, Yamout BI. Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring. BMC Neurol, 2014 Feb 12; 14(1):27. [Epub ahead of print]

-Yamout B, Alroughani R, Al-Jumah M, Goueider R, Dahdaleh M, Inshasi J, Hashem S, Alsharoqi I, Sahraian M, Khoury S, Alkawi Z, Koussa S, Zakaria M, Al Khaburi J, Alsaadi T, Bohlega S. Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS). Curr Med Res Opin, 2015;31(7):1349-61. doi: 10.1185/03007995.2015.1047750. Epub 2015 May 29.

Oral presentations accepted by a board of scientific reviewers:
-P Bouche, S Koussa, JM Léger, HP Cathala. Réponse cutanée sympathique : étude des fibres non myélinisées. VIèmes Journées Francophones d’Électromyographie. Lille, juin 1988   
-A Moulonguet, S Koussa, JM Léger, P Bouche, HP Cathala. Le réflexe cutané sympathique dans la SLA. IXièmes Journées Internationales de Pathologie Neuromusculaire. Marseille, septembre 1988
-JC Gautier, S Koussa, JB Juillard, P Pradat-Diehl. Signification des embolies cérébrales cardiogéniques dans les infarctus cérébraux. XVII cours international de perfectionnement : actualités en maladies de la circulation sanguine. Tirana, septembre 1989
-JC Gautier, S Koussa, A Majdalani. Anévrysmes disséquants des deux artères carotides internes. Société Médicale des Hôpitaux de Paris. Paris, octobre 1989
-JC Gautier, S Koussa, A Dürr, G Lascault, Y Grosgogeat. Embolies cérébrales paradoxales et foramen ovale perméable. Société Française de Neurologie. Paris, janvier 1991
-S Koussa. Neuropathie optique et troubles oculomoteurs au cours du diabète. Congrès de la Société libanaise d’Endocrinologie. Beyrouth, 1992
-S Koussa. Electrophysiology in the diagnosis of cervical myelopathy. Syrian-Lebanese 1st Neurosciences Meeting. Damascus, 1992
-S Koussa. Intérêt des potentiels évoqués sensitifs dans les myélopathies cervicales.  Société Libanaise de Neurologie. Beyrouth, novembre 1993
-S Koussa. Cerebral palsy. First head and neck pain meeting in the Middle East. Beirut, September 1994
-S Koussa. Explorations neurophysiologiques. Programme de Formation Continue de l’Hôpital Ain Wazein avec le consorlum des O.N.G. de Belgique. Juillet  1995
-S Koussa.  Spontaneous extracranial carotid artery dissection: atypical clinical features. European Pan-Arab Neuro-Surgical Congress. Beirut, October 1997
-S Koussa. L’algie vasculaire de la face: une entité mal connue. VIIIième congrès international de l’Ordre des Dentistes du Liban et VIème congrès de l’Union des Associations Dentaires Arabes. Beyrouth, août 1998
-S Koussa. Physiopathologie des nausées et vomissements post-opératoires. Société Libanaise de Chirurgie Générale. Beyrouth, octobre 1998 
-R Chémaly, A Tohmé, S Koussa, K Kallab, E Ghayad, R Nasnas. Neurobrucellose. Neuroméditerranée. Marseille, mars 1999
-S Koussa. Development of Multiple Sclerosis Functional Composite (invited lecturer). The VIIIth Pan Arab Union of Neurol Sciences Conference. Beirut, April 2000
-R Chémaly, K Kallab, S Koussa, R Baddoura. Epidémiologie de la Sclérose en Plaques dans un échantillon libanais. Neuroméditerranée. Hammamet (Tunisie), juin 2000
-S Koussa, K Abou Khaled, R Chémaly. Isolated vertigo as a manifestation of stroke. The VIIIth Pan Arab Union of Neurol Sciences Conference. Beirut, April 2000
-S Koussa, S Slaba. Reperméabilisation à la phase aiguë de l’AVC. Deuxième Congrès International de l’Association Franco-Libanaise de Cardiologie. Beyrouth, juin 2001
-S Koussa. Sclérose en Plaques : actualités thérapeutiques. Société Marocaine de Neurologie. Marrakech, octobre 2001
-S Koussa. Syncope : définition et étiologies. Société Libanaise de Cardiologie. Beyrouth, janvier 2002
-S Koussa. L’état de mal à domicile. Symposium sur la prise en charge pré-hospitalière en urgence. Beyrouth, février 2002  
-R Chémaly, S Koussa, K Kallab, S Slaba. Thromolytic therapy in acute stroke: experience of the Hôtel-Dieu de France in Beirut. First French-Syrian Congress of Neurology. Damascus, May 2002
-S Koussa. Control of hypertension in the primary and secondary prevention of stroke. IIIrd Regional Hypertension Congress. Beirut, July 2002
-S Koussa. EMG in back pathologies. Lebanese Society of Neurology. Beirut, July 2002
-S Koussa. Preventing stroke beyond blood pressure lowering. Symposium for general practitioners. Beirut, February 2003
-S Koussa. Place de l’électrodiagnostic dans les radiculopathies cervicales. Journées Neurologiques de Langue Française. Nantes, avril 2003
-S Koussa. Aspect clinique des radiculomyélopathies cervicales. Journées Neurologiques de Langue Française. Nantes, avril 2003
-S Koussa. Therapy of partial seizures. Epilepsy Forum: Management of Epilepsy: therapy of partial seizures. Jordan, September 2003
-S Koussa.  Brain death in organ donation.  The first annual congress on transplantation and organ donation. Tripoli, July 2003 
-S Koussa, S Klayme, M Ayache, M Azoury, R Naaman. The HLA locus and multiple sclerosis in Lebanon. Eighth Congress of the European Federation of Neurological Societies. Paris, September 2004
-M Riachy, F Sfeir, G Sleilaty, G Dabar, Z Aoun-Bacha, G Khayat, S Koussa. Prediction of Survival and Disability of Severe Stroke Patients Admitted to the Intensive Care Unit. Eigth Pan Arab Congress of Anesthesia, Intensive Care and Pain Management. Beirut, September 2004
-A Tohmé, B el Rassi, S Koussa, R Nasnas. Human brucellosis : clinical features and therapeutical responses in 92 patients. European Congress of Chemotherapy- Réunion interdisciplinaire de chimiothérapie anti-infectieuse. Paris, décembre 2004
-S Koussa, A Tohmé, F Haddad, E Ghayad. Manifestations neurologiques de la maladie de Behçet : étude de 16 observations. Neuroméditerranée VII. Damas, mai 2005
-S Koussa. Rôle du neurologue dans la prise en charge de la douleur. HDF-Hospices Civils de Lyon. Beyrouth, avril 2006
-S Koussa, S Hage Chahine, A Zoghbi, P Yazbeck. Etat de mal épileptique et gatifloxacine. Neuroméditerranée VIII. Mer Morte (Jordanie), novembre 2006
-K Abou Khaled, S Koussa, R Chémaly. Isolated vertigo as a manifestation of stroke. Neuroméditerranée VIII. Dead Sea (Jordany), November 2006
-S Koussa. Hemichorea-hemiballism and non-ketotic hyperglycemia. VIIIth Cairo International Neurology Conference. Cairo, February 2007
-S Koussa. Heroin induced leucoencephalopathy. Neuroméditerranée IX. Marseille, November 2007
-S Koussa. Heroin induced leucoencephalopathy. Neuroméditerranée IX, Marseille, November 2007
-S Koussa. Headaches and migraines: management in primary care setting. The National Congress of the Lebanese Society of General Practice. Beirut, May 2009
-S Koussa. Upper neck and occipital pain. The 2009 Society for Progress and Innovation for the Near East (SPINE). Beirut, July 2009
-S Koussa. Medical management of migraines. The 2009 Society for Progress and Innovation for the Near East (SPINE). Beirut, July 2009
-S Koussa. Management issues of women with epilepsy. The 6th Annual Congress of the Lebanese Order of Physicians-Tripoli. Tripoli, March 2010
-S Koussa. Botulinum toxin in temporo-mandibular joint disease. International College of Dentists. Beirut, April 2010
-S Koussa. Ocular and early manifestations of multiple sclerosis. The 5th Annual Meeting of The Lebanese Society of Neurology. Beirut, April 2010
-S Koussa. The Eastern European and Mediterranean Cerebral Palsy and Developmental Medicine Conference. Botulinum toxin in spasticity secondary to stroke. Beirut, May 2010
-S Koussa. Officine neurological cases for primary care physician. Lebanese Society of General Practice Meeting. Beirut, May 2010
-S Koussa. Alzheimer et escarre. Troisièmes journées de l’escarre de l’HDF. Beyrouth, juin 2010
-S Koussa. Cerebellar infarcts- a clinical update. The scientific convention of the Islamic Medical Association of Lebanon & the federation of Islamic Medical Association. Beirut, September 2010
-SKoussa, A Megarbane. Megalencephalic leucoencephalopathy with subcortical cysts. Neuroméditerranée XI. Beirut, September 2010
-S Koussa. The new era in treating multiple sclerosis. XVIIIth pharmaceutical congress of the Lebanese Order of Pharmacists.  Beirut, October 2010
-S Koussa. Syncope: state of the art. Lebanese Society of Internal Medicine, Beirut, October 2010
-S Koussa. The new era in the treatment of Multiple Sclerosis. Lebanese Society of Internal Medicine, Beirut, October 2010
-S Koussa. Neuroimmunology: What Emergency Physicians Should Know. The 4th Annual Conference of the Lebanese Society for Emergency Medicine. Beirut, November 2010
-S Koussa. Acute neurological emergencies & interventional neurology. The 4th Annual Conference of the Lebanese Society for Emergency Medicine. Beirut, November 2010
-S Koussa. Emergence of oral treatment options in multiple sclerosis. Lebanese Society of Internal Medicine. Beirut, March 2011
-S Koussa.  Rivastigmin patch: what is the rational for a switch. Lebanese Society of Internal Medicine. Beirut, April 2011
-F Haddad, M Jammal, G Maalouly, R Abi Saleh, D Chehwane, S Koussa.  “B12” normal associé à des troubles cognitifs: mythe ou réalité? 63ème congrès de la SNFM. Poitiers, juin 2011 
-S Koussa.  OLSEP data / les données de l’OLSEP.   The 5th International Congress of the Lebanese Society of Neurology. Beirut, 16th November 2013
-S. Koussa. Multiple Sclerosis Guidelines. The 7th International Congress of the Lebanese Society of Neurology. Beirut, 27-29 November 2015
-R Jabbour, V Delague, A Megarbane, J Irani, K Kallab, H Abdel Samad, S Koussa. Epidemiology of Charcot-Marie-Tooth in Lebanon. The 7th International Congress of the Lebanese Society of Neurology. Beirut, 27-29 November 2015
-S. Koussa. Clinically isolated syndrome. 13th International MS Congress of Iran. Teheran, February 2017
-S. Koussa. Unmet needs in multiple sclerosis treatment. 14th International MS Congress of Iran. Keesh, December 2017
-S. Koussa. New disease modifying treatments in MS. Syrian Society Congress. Damascus, June 19, 2019